Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 81
Optical 75
Immune Disorders Drugs 73
Optical Disorders Drugs 68
Drug Discovery 54
Cardiovascular Drugs 46
Biopharmaceuticals 37
Dermatological Drugs 37
Musculoskeletal Disorders Drugs 37
Biotechnology 33
Genomics 28
Clinical Trials 22
Central Nervous System Drugs 19
Pharmaceuticals 19
Skin Cancer Drugs 19
Endocrine and Metabolic Disorders Drugs 19
Infectious Diseases Drugs 18
Allergy and Immunology 17
Drugs by Therapeutic Area 16
Respiratory Drugs 15
Infusions and Injectables 14
Allergy Drugs 13
Lung Cancer Drugs 12
Gastrointestinal Drugs 11
Dermatology 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Diagnostics 7
Biosimilars and Biosuperiors 7
Pharmaceutical Manufacturing 7
Prostate Cancer Drugs 6
Enzymes 6
Vaccines 6
Asthma Drugs 6
Therapeutic Area 5
Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Gastroenterology 5
Company Reports 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Cardiovascular Devices 3
Medical Devices 3
Pediatrics 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Analgesics 2
Cough and Cold Drugs 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Anti-Obesity Drugs 2
Cardiology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

682 Results (Page 16 of 35)
- Relevance
  Sort by

LAMEA Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Middle East, Africa

From

€1337EUR$1,500USD£1,161GBP

Europe Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Europe

From

€1337EUR$1,500USD£1,161GBP

Asia Pacific Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Asia Pacific

From

€1337EUR$1,500USD£1,161GBP

Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
63 Pages
Global

From

€1783EUR$2,000USD£1,548GBP

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
210 Pages
Global

From

€1783EUR$2,000USD£1,548GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Immune Checkpoint Inhibitors for Lung Cancer Market - Global Forecast 2025-2032

 Report
October 2025
198 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Non-small Cell Lung Cancer Therapeutics Market - Global Forecast 2025-2032

 Report
October 2025
195 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Prostate Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2675EUR$3,000USD£2,321GBP

Metastatic Castration-Resistant Prostate Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2675EUR$3,000USD£2,321GBP

Melanoma Drug Market - Global Forecast 2025-2032

 Report
October 2025
184 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Biologic & Biosimilar RA Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4003EUR$4,490USD£3,474GBP

Peanut Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
May 2025
180 Pages
Global

From

€4012EUR$4,500USD£3,482GBP

Beta Nerve Growth Factor - Pipeline Review, H2 2020

 Drug Pipelines
July 2020
61 Pages
Global

From

€3121EUR$3,500USD£2,708GBP

Small Cell Lung Cancer Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4003EUR$4,490USD£3,474GBP

Basal Cell Carcinoma Treatment Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3700EUR$4,150USD£3,211GBP

Allergic Rhinitis - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1783EUR$2,000USD£1,548GBP

Lung Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4003EUR$4,490USD£3,474GBP

Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
104 Pages
Global

From

€1783EUR$2,000USD£1,548GBP

Nasal Drug Delivery Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4003EUR$4,490USD£3,474GBP

Viral Gastroenteritis Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4003EUR$4,490USD£3,474GBP

682 Results (Page 16 of 35)
- 1
- 14
- 15
- 16
- 17
- 18

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.